The challenge of peripheral arterial disease: How do we improve outcome?

ATHEROSCLEROSIS

卷 270, 期 -, 页码 196-198

ELSEVIER IRELAND LTD

Peripheral arterial disease (PAD); Atherosclerotic cardiovascular disease (ASCVD); Multiple vascular beds; Antiplatelet agents; Statin; Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; Cardiovascular; FOURIER; CHD; Hypertension; MI, stroke or cardiovascular death; MACE; Kaplan-Meier rate; LDL-C reduction; Stroke; Kaplan-Meier period; PCSK9 inhibitor

Cardiac & Cardiovascular Systems Peripheral Vascular Disease